Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone
Jinsong Liu,1,* Youyun Zeng,1,* Shuai Shi,2 Lihua Xu,3 Hualin Zhang,4 Janak L Pathak,5 Yihuai Pan1 1School and Hospital of Stomatology, 2Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, 3The First Affiliated Hospital of W...
Enregistré dans:
Auteurs principaux: | Liu JS, Zeng Y, Shi S, Xu L, Zhang HL, Pathak JL, Pan Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cfb05d98a2a8464fae82efb37b65265c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)–poly(ethylene glycol) for long-term sustained release
par: Duan JW, et autres
Publié: (2018) -
Non-Isothermal Crystallization Kinetics of Poly(ethylene glycol) and Poly(ethylene glycol)-B-Poly(ε-caprolactone) by Flash DSC Analysis
par: Xiaodong Li, et autres
Publié: (2021) -
A polypropylene mesh modified with poly-ε-caprolactone nanofibers in hernia repair: large animal experiment
par: East B, et autres
Publié: (2018) -
Management of bone metastases in refractory prostate cancer – role of denosumab
par: Paller CJ, et autres
Publié: (2012) -
Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)- poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors
par: Niu Y, et autres
Publié: (2014)